Archives

Colibri Heart Valve Advances Second-Generation TAVI System into Clinical Feasibility Study

Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that the first two patients have been...

Colibri Heart Valve Announces Issuance of a Patent for a Pre‐mounted, Pre‐packaged, Sterilized Dry Heart Valve on a Delivery System

Colibri Heart Valve, LLC, a privately held medical device company, has been granted yet another patent directed to prosthetic heart...

Colibri Heart Valve 2017 Summer Internship Program

Colibri Heart Valve LLC, a privately held emerging medical device company focused on structural heart applications, has partnered with the...

Colibri Heart Valve Receives ISO 13485 and EN ISO 13485 Certification

Colibri Heart Valve LLC, a privately held emerging medical device company focused on structural heart applications, announced today that it...

Colibri Heart Valve Receives European Patent for a Method of Making a Pre-packaged, Sterilized Dry Heart Valve, Pre-mounted on a Delivery Catheter

Colibri Heart Valve LLC, a privately held emerging medical device company, has received notification from the European Patent Office that...

Colibri Heart Valve Forms a New Entity to Monetize Tissue Processing Technology in Applications Outside of Structural Heart

Colibri Heart Valve LLC, a privately held emerging medical device company focused on structural heart applications, announces the formation of...

Colibri Heart Valve Strengthens Patent Portfolio with Receipt of 12th Transcatheter Heart Valve (THV) Patent

Colibri Heart Valve LLC, a privately held emerging medical device company, has received an Issue Notification from the U.S. Patent...

Colibri Heart Valve Receives Patent for Controlled Release of a Percutaneous Heart Valve Device and Strengthens Management Team

Colibri Heart Valve, LLC, a privately held emerging medical device company, has received its 8th allowed/granted patent directed to transcatheter...

Colibri Heart Valve’s TAVI System Continues to Show Positive Long-Term Results from its First-in-Human Clinical Study

Colibri Heart Valve, LLC, a privately held emerging medical device company, today announced that long-term results on patients enrolled in...

Colibri Heart Valve to Present Long-Term Results from the Company’s First-in-Human Clinical Study and Exhibit at Upcoming EuroPCR Meeting

Colibri Heart Valve, LLC, a privately held emerging medical device company, today announced that Dr. Bernard Chevalier will present long-term...